The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
Authors
Keywords
-
Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-20
DOI
10.1007/s11154-022-09782-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
- (2022) Pedro Marques et al. Pituitary
- Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation
- (2022) Valentina Guarnotta et al. Nutrients
- Second line treatment of acromegaly: Pasireotide or Pegvisomant?
- (2022) Sabrina Chiloiro et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review
- (2022) Mirela Diana Ilie et al. ENDOCRINE-RELATED CANCER
- Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas
- (2022) Mirela-Diana ILIE et al. ENDOCRINE REVIEWS
- Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression
- (2021) Yu Mei et al. Pituitary
- From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact on the Therapeutic Management?
- (2021) Sabrina Chiloiro et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly
- (2021) Giovanni Tulipano et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
- (2021) Jing Guo et al. Frontiers in Genetics
- Aggressive pituitary tumours and pituitary carcinomas
- (2021) Gérald Raverot et al. Nature Reviews Endocrinology
- Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte Ratios, and Systemic Immune-Inflammation Index as Potential Biomarkers of Chronic Inflammation in Patients with Newly Diagnosed Acromegaly: A Single-Centre Study
- (2021) Joanna Szydełko et al. Journal of Clinical Medicine
- The changing clinical spectrum of endocrine adverse events in cancer immunotherapy
- (2021) Sabrina Chiloiro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
- (2021) Changxi Han et al. Frontiers in Endocrinology
- Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
- (2020) Mônica Gadelha et al. Frontiers in Endocrinology
- How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
- (2020) Jacqueline Trouillas et al. Cancers
- Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
- (2020) Mirela Diana Ilie et al. Cancers
- The tumour microenvironment of pituitary neuroendocrine tumours
- (2020) Pedro Marques et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
- (2020) Zihao Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
- (2020) Jacqueline Trouillas et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
- (2020) Bastiaan Sol et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas
- (2020) Wenjianlong Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches
- (2020) David M. Weiner et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pre-operative serum inflammation-based scores in patients with pituitary adenomas
- (2020) Pedro Marques et al. Pituitary
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy
- (2020) Lydia S. Lamb et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response
- (2020) Sabrina Chiloiro et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Current advancements and future perspectives of immunotherapy in colorectal cancer research
- (2020) Chandra Kishore et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools
- (2019) Qingxia Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apatinib (YN968D1) and temozolomide in recurrent invasive pituitary adenoma: case report and literature review
- (2019) Yong Wang et al. World Neurosurgery
- Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States
- (2019) Spencer C. Wei et al. IMMUNITY
- Surgery, octreotide, temozolomide, bevacizumab, radiotherapy and pegvisomant treatment of an AIP mutation positive child
- (2019) Pinaki Dutta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Changing Clinical Spectrum of Hypophysitis
- (2019) Sabrina Chiloiro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Emerging and Novel Treatments for Pituitary Tumors
- (2019) Ilie et al. Journal of Clinical Medicine
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
- (2019) Mirela Diana Ilie et al. Cancers
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
- (2019) Pedro Marques et al. ENDOCRINE-RELATED CANCER
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Advances in studies of tyrosine kinase inhibitors and their acquired resistance
- (2018) Qinlian Jiao et al. Molecular Cancer
- Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy
- (2018) Rosario Amato et al. PHARMACOLOGICAL RESEARCH
- Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α–mediated tumor progression
- (2018) Na Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK
- (2017) Thalijn Liliana Catharina Wolters et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Programmed cell senescence: role of IL-6 in the pituitary
- (2017) Melanie Sapochnik et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma
- (2017) Mohamed M. Aboelnaga et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
- (2016) Patrizio Caturegli et al. AMERICAN JOURNAL OF PATHOLOGY
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors
- (2016) Marie Chanal et al. MOLECULAR CANCER THERAPEUTICS
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Tumor microenvironment: Sanctuary of the devil
- (2015) Lanlan Hui et al. CANCER LETTERS
- IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
- (2015) Z. Sun et al. CANCER RESEARCH
- Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas
- (2015) M. Lee et al. CLINICAL CANCER RESEARCH
- Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
- (2015) Jian-Qiang Lu et al. ENDOCRINE PATHOLOGY
- The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
- (2014) Eric Monsalves et al. ENDOCRINE-RELATED CANCER
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful Mortality Reduction and Control of Comorbidities in Patients With Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic
- (2014) Moises Mercado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inflammation-Based Scores: A New Method for Patient-Targeted Strategies and Improved Perioperative Outcome in Cancer Patients
- (2014) Dario Bugada et al. Biomed Research International
- mTOR is Frequently Active in GH-Secreting Pituitary Adenomas without Influencing their Morphopathological Features
- (2013) Emir Ahmed Sajjad et al. ENDOCRINE PATHOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Expression of T-helper-associated cytokines in the serum of pituitary adenoma patients preoperatively and postperatively
- (2013) Lubin Qiu et al. MEDICAL HYPOTHESES
- Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet
- (2012) V. Touskova et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- VEGF and CD31 Association in Pituitary Adenomas
- (2010) Carolina Cristina et al. ENDOCRINE PATHOLOGY
- Intrapituitary Expression and Regulation of the gp130 Cytokine Interleukin-6 and Its Implication in Pituitary Physiology and Pathophysiology
- (2009) Ulrich Renner et al. Annals of the New York Academy of Sciences
- The pathophysiology of pituitary adenomas
- (2009) Dorota Dworakowska et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
- (2009) Alexander Gorshtein et al. ENDOCRINE-RELATED CANCER
- Regulation of Pituitary Function by Cytokines
- (2009) Mariana R. Haedo et al. HORMONE RESEARCH
- Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma
- (2009) Isabella Lupi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The significance of Treg cells in defective tumor immunity
- (2008) Agata Kosmaczewska et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Tumor-host interactions: the role of inflammation
- (2008) Marie-Aude Bitoux et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Failure of T cell homing, reduced CD4/CD8 intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice
- (2008) S. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolactin, dendritic cells, and systemic lupus erythematosus
- (2007) Luis J. Jara et al. AUTOIMMUNITY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now